View Document Preview and Link Document Date: 2014-11-05 17:48:07 Open Document File Size: 694,89 KB Share Result on Facebook
City Cincinnati / New York / / Company Administrator Intellectual Property Department Provider Synergies L.L.C. / Lilly / ACE / Hypoglycemics / Provider Synergies L.L.C. / Merck / Magellan Medicaid Administration Inc. / Novo Nordisk / Bristol-Myers Squibb / / / Event FDA Phase / / Facility American College of Endocrinology / / IndustryTerm food / food intake / diabetes treatment / / MedicalCondition acidosis / colorectal cancer / chronic renal failure / MEN 2 / Multiple Endocrine Neoplasia / nausea / anaphylaxis / persistent postprandial hyperglycemia / concurrent illness / Stevens-Johnson syndrome / unstable angina / diabetic ketoacidosis / obesity / chronic pancreatitis / diarrhea / hypersensitivity / end stage renal disease / bronchial hyperreactivity / end-stage renal disease / hypoglycemia / pancreatic cancer / sepsis / hepatic insufficiency / pancreatic neoplasm / abdominal pain / congestive heart failure / gastroparesis / insulin resistance / cancer / vasculitis / tumors / disease / gastrointestinal disease / ESRD / stroke / diabetes / cardiovascular disease / vomiting / renal insufficiency / myocardial infarction / thyroid carcinoma / lactic acidosis / heart failure / hepatic failure / urticaria / angioedema / pancreatitis / type 1 diabetes mellitus / rash / acute renal failure / respiratory distress / dehydration / / MedicalTreatment peritoneal dialysis / renal transplantation / kidney transplantation / insulin therapy / complementary therapy / statin therapy / hemodialysis / drug therapy / / Organization Pharmacy and Therapeutics committee / American Academy of Clinical Endocrinologists / American Diabetes Association / ADA/European Association for the Study of Diabetes / US Federal Reserve / the American College / FDA / Medicaid Agency / / Position physician / / Product pioglitazone / Janumet / Byetta / simvastatin / glucagon / glimepiride / Symlin / Januvia / metformin hydrochloride / INDICATIONS Drug / TIMI-53 / / ProvinceOrState Ohio / Michigan / / PublishedMedium Endocrinology / / Technology alpha / Incretin Mimetics/ Enhancers Review algorithm / antibodies / transplantation / PHARMACOKINETICS / 2013 AACE algorithm / CVD / dialysis / / SocialTag 
Hypoglycemics, Incretin Enhancers/Mimetics